Evaluation of the efficacy of real-time polymerase chain reaction for the routine early detection of Pseudomonas aeruginosa in cystic fibrosis sputum and throat swab specimens

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 4, 2010, Pages 358-365

  Logan, Catriona ^a   Habington, Adele ^a   Lennon, Gráinne ^a   Cronin, Frank ^a   O'Sullivan, Niamh ^a,b  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b Tallaght and Coombe Women's and Infant's University Hospital   (Ireland)

Author keywords

Cystic fibrosis; Pseudomonas aeruginosa; Real time PCR

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) B; GUANOSINE DIPHOSPHATE MANNOSE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FALSE NEGATIVE RESULT; HUMAN; INFANT; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; THROAT CULTURE;

ADOLESCENT; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; CYSTIC FIBROSIS; DNA, BACTERIAL; EARLY DIAGNOSIS; HUMANS; INFANT; INFANT, NEWBORN; PHARYNX; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; SPUTUM; YOUNG ADULT;

EID: 78649248397     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.07.012     Document Type: Article

References (36)

1. Al-Aloul M., Crawley J., Winstanley C., Hart C.A., Ledson M., Walshaw M.J. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004, 59:334-336.
2. Anthony M., Rose B., Pegler M.B., Elkins M., Service H., Thamotharampillai K., Watson J., Robinson M., Bye P., Merlino J., Harbour C. Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J. Clin. Microbiol. 2002, 40:2772-2778.
3. Anuj S.N., Whiley D.M., Kidd T.J., Bell S.C., Wainwright C.E., Nissen M.D., Sloots T.P. Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn. Microbiol. Infect. Dis. 2009, 63:127-131.
4. Armstrong D.S., Grimwood K., Carlin J.B., Carzino R., Gutierrez J.P., Hull J., Olinsky A., Phelan E.M., Robertson C.F., Phelan P.D. Lower airway inflammation in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 1997, 156:1197-1204.
5. Cheng K., Smyth R.L., Govan J.R., Doherty C., Winstanley C., Denning N., Heaf D.P., van Saene H., Hart C.A. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996, 348:639-642.
6. Clarke L., Moore J.E., Millar B.C., Garske L., Xu J., Heuzenroeder M.W., Crowe M., Elborn J.S. Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients. J. Med. Microbiol. 2003, 52:759-763.
7. da Silva Filho L.V., Tateno A.F., Martins K.M., Azzuz Chernishev A.C., Garcia Dde O., Haug M., Meisner C., Rodrigues J.C., Doring G. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatr. Pulmonol. 2007, 42:938-944.
8. Davies J.C. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr. Respir. Rev. 2002, 3:128-134.
9. Deschaght P., De Baere T., Van Simaey L., Van Daele S., De Baets F., De Vos D., Pirnay J.P., Vaneechoutte M. Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol. 2009, 9:244-250.
10. Doring G., Conway S.P., Heijerman H.G., Hodson M.E., Hoiby N., Smyth A., Touw D.J. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur. Respir. J. 2000, 16:749-767.
11. Frederiksen B., Koch C., Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr. Pulmonol. 1997, 23:330-335.
12. Hansen C.R., Pressler T., Hoiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J. Cyst. Fibros. 2008, 7:523-530.
13. Henry R.L., Mellis C.M., Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr. Pulmonol. 1992, 12:158-161.
14. Jelsbak L., Johansen H.K., Frost A.L., Thogersen R., Thomsen L.E., Ciofu O., Yang L., Haagensen J.A., Hoiby N., Molin S. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun. 2007, 75:2214-2224.
15. Jones A.M., Govan J.R., Doherty C.J., Dodd M.E., Isalska B.J., Stanbridge T.N., Webb A.K. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001, 358:557-558.
16. Kerem E., Corey M., Gold R., Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J. Pediatr. 1990, 116:714-719.
17. Kosorok M.R., Zeng L., West S.E., Rock M.J., Splaingard M.L., Laxova A., Green C.G., Collins J., Farrell P.M. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr. Pulmonol. 2001, 32:277-287.
18. Lewis D.A., Jones A., Parkhill J., Speert D.P., Govan J.R., Lipuma J.J., Lory S., Webb A.K., Mahenthiralingam E. Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. Am. J. Respir. Cell Mol. Biol. 2005, 33:56-64.
19. Logan C., O'Leary J.J., O'Sullivan N. Real-time reverse transcription-PCR for detection of rotavirus and adenovirus as causative agents of acute viral gastroenteritis in children. J. Clin. Microbiol. 2006, 44:3189-3195.
20. Logan C., O'Leary J.J., O'Sullivan N. Real-time reverse transcription PCR detection of norovirus, sapovirus and astrovirus as causative agents of acute viral gastroenteritis. J. Virol. Methods 2007, 146:36-44.
21. McCallum S.J., Corkill J., Gallagher M., Ledson M.J., Hart C.A., Walshaw M.J. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet 2001, 358:558-560.
22. McCallum S.J., Gallagher M.J., Corkill J.E., Hart C.A., Ledson M.J., Walshaw M.J. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax 2002, 57:559-560.
23. Nixon G.M., Armstrong D.S., Carzino R., Carlin J.B., Olinsky A., Robertson C.F., Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J. Pediatr. 2001, 138:699-704.
24. O'Carroll M.R., Syrmis M.W., Wainwright C.E., Greer R.M., Mitchell P., Coulter C., Sloots T.P., Nissen M.D., Bell S.C. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur. Respir. J. 2004, 24:101-106.
25. Parsons Y.N., Panagea S., Smart C.H., Walshaw M.J., Hart C.A., Winstanley C. Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. J. Clin. Microbiol. 2002, 40:4607-4611.
26. Qin X., Emerson J., Stapp J., Stapp L., Abe P., Burns J.L. Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis. J. Clin. Microbiol. 2003, 41:4312-4317.
27. Rabin H.R., Butler S.M., Wohl M.E., Geller D.E., Colin A.A., Schidlow D.V., Johnson C.A., Konstan M.W., Regelmann W.E. Pulmonary exacerbations in cystic fibrosis. Pediatr. Pulmonol. 2004, 37:400-406.
28. Renders N.H., Sijmons M.A., van Belkum A., Overbeek S.E., Mouton J.W., Verbrugh H.A. Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res. Microbiol. 1997, 148:447-454.
29. Smart C.H., Walshaw M.J., Hart C.A., Winstanley C. Use of suppression subtractive hybridization to examine the accessory genome of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa. J. Med. Microbiol. 2006, 55(Pt 6):677-688.
30. Speert D.P., Campbell M.E., Henry D.A., Milner R., Taha F., Gravelle A., Davidson A.G., Wong L.T., Mahenthiralingam E. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am. J. Respir. Crit. Care Med. 2002, 166:988-993.
31. Speert D.P., Farmer S.W., Campbell M.E., Musser J.M., Selander R.K., Kuo S. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis. J. Clin. Microbiol. 1990, 28:188-194.
32. Spilker T., Coenye T., Vandamme P., LiPuma J.J. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J. Clin. Microbiol. 2004, 42:2074-2079.
33. Tramper-Stranders G.A., van der Ent C.K., Wolfs T.F. Detection of Pseudomonas aeruginosa in patients with cystic fibrosis. J. Cyst. Fibros. 2005, 4(Suppl 2):37-43.
34. Valerius N.H., Koch C., Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991, 338:725-726.
35. Wahba A.H., Darrell J.H. The identification of atypical strains of Pseudomonas aeruginosa. J. Gen. Microbiol. 1965, 82:380-390.
36. Xu J., Moore J.E., Murphy P.G., Millar B.C., Elborn J.S. Early detection of Pseudomonas aeruginosa-comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF). Ann. Clin. Microbiol. Antimicrob. 2004, 3:21-25.